The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US
Editors Discuss The Latest Developments For Ustekinumab Rivals
In the wake of multiple ustekinumab biosimilar rivals to Stelara launching in the US at the end of February, Generics Bulletin’s editors discuss the market dynamics and the latest key developments.
